Literature DB >> 1821668

Morphine responders with unexplained pain after cholecystectomy may have sympathetic overactivity.

I C Roberts-Thomson1, J R Jonsson, P R Pannall, D B Frewin.   

Abstract

In patients with unexplained pain after cholecystectomy, morphine often induces pain and may increase plasma aspartate aminotransferase activity because of exaggerated or prolonged rises in pressure within the biliary system. Previous studies have demonstrated that patients showing increases in aspartate aminotransferase have increases in plasma concentrations of noradrenaline and dopamine prior to and soon after induction of pain. The purpose of this study was to assess sympathetic activity under basal conditions in patients with (responders) and without (non-responders) increases in aspartate aminotransferase after challenge with morphine. When compared to non-responders, morphine responders had higher plasma concentrations of noradrenaline (p = 0.0001) and dopamine (p = 0.02) and higher urinary excretion of noradrenaline over 24 h (p = 0.03). Plasma and urinary levels of adrenaline were similar in the two groups. These observations indicate higher basal levels of sympathetic activity in the subgroup of patients showing increases in aspartate aminotransferase after challenge with morphine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821668     DOI: 10.1007/BF01826059

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  19 in total

1.  Altered autonomic function in patients with arthritis or with chronic myofascial pain.

Authors:  Franklin Perry; Philip H Heller; Joe Kamiya; Jon D Levine
Journal:  Pain       Date:  1989-10       Impact factor: 6.961

2.  Measurements of autonomic function before, during, and after transcutaneous stimulation in patients with chronic pain and in control subjects.

Authors:  M J Ebersold; E R Laws; J W Albers
Journal:  Mayo Clin Proc       Date:  1977-04       Impact factor: 7.616

3.  Diagnosis of reflex sympathetic dysfunction. Use of the skin potential response.

Authors:  K D Cronin; R L Kirsner; V P Fitzroy
Journal:  Anaesthesia       Date:  1982-08       Impact factor: 6.955

4.  Pain after cholecystectomy.

Authors:  I C Roberts-Thomson
Journal:  Med J Aust       Date:  1985-11-25       Impact factor: 7.738

5.  Abnormal responses to morphine-neostigmine in patients with undefined biliary type pain.

Authors:  I C Roberts-Thomson; J Toouli
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

6.  Biochemical indices of sympathetic activity in migraine.

Authors:  M Anthony
Journal:  Cephalalgia       Date:  1981-06       Impact factor: 6.292

7.  Innervation of the gall bladder and biliary pathways in the guinea-pig.

Authors:  W Q Cai; G Gabella
Journal:  J Anat       Date:  1983-01       Impact factor: 2.610

8.  Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbits.

Authors:  C N May; I W Ham; K E Heslop; F A Stone; C J Mathias
Journal:  Clin Sci (Lond)       Date:  1988-07       Impact factor: 6.124

9.  Morphine effects on locus ceruleus neurons are dependent on the state of arousal and availability of external stimuli: studies in anesthetized and unanesthetized rats.

Authors:  R J Valentino; R G Wehby
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

10.  Relationship between morphine responses and sphincter of Oddi motility in undefined biliary pain after cholecystectomy.

Authors:  I C Roberts-Thomson; P R Pannall; J Toouli
Journal:  J Gastroenterol Hepatol       Date:  1989 Jul-Aug       Impact factor: 4.029

View more
  2 in total

Review 1.  Sphincter of Oddi dysfunction: is there a role for medical therapy?

Authors:  Alexander Craig; James Toouli
Journal:  Curr Gastroenterol Rep       Date:  2002-04

2.  Sympathetic suppression attenuates anomalous responses to morphine in unexplained pain after cholecystectomy.

Authors:  I C Roberts-Thomson; J R Jonsson; D B Frewin
Journal:  Clin Auton Res       Date:  1994-08       Impact factor: 4.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.